Angus C. Russell - Net Worth and Insider Trading
Angus C. Russell Net Worth
The estimated net worth of Angus C. Russell is at least $196,976 dollars as of 2024-11-13. Angus C. Russell is the Director of Revance Therapeutics Inc and owns about 26,913 shares of Revance Therapeutics Inc (RVNC) stock worth over $111,151. Angus C. Russell is the Director of Lineage Cell Therapeutics Inc and owns about 87,500 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $83,020. Angus C. Russell is also the Director of TherapeuticsMD Inc and owns about 1,870 shares of TherapeuticsMD Inc (TXMD) stock worth over $2,805. Besides these, Angus C. Russell also holds Mallinckrodt PLC (MNKKQ) . Details can be seen in Angus C. Russell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Angus C. Russell has not made any transactions after 2021-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Angus C. Russell
Angus C. Russell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Angus C. Russell owns 5 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , TherapeuticsMD Inc (TXMD) , and Revance Therapeutics Inc (RVNC) among others .
Click here to see the complete history of Angus C. Russell’s form 4 insider trades.
Insider Ownership Summary of Angus C. Russell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2021-06-29 | director |
| TXMD | TherapeuticsMD Inc | 2022-08-18 | director |
| RVNC | Revance Therapeutics Inc | 2021-12-13 | director |
 | | 2022-06-16 | director |
| | 2022-06-16 | director |
Angus C. Russell Latest Holdings Summary
Angus C. Russell currently owns a total of 4 stocks. Among these stocks, Angus C. Russell owns 26,913 shares of Revance Therapeutics Inc (RVNC) as of December 13, 2021, with a value of $111,151 and a weighting of 56.43%. Angus C. Russell owns 87,500 shares of Lineage Cell Therapeutics Inc (LCTX) as of June 29, 2021, with a value of $83,020 and a weighting of 42.15%. Angus C. Russell also owns 1,870 shares of TherapeuticsMD Inc (TXMD) as of August 23, 2019, with a value of $2,805 and a weighting of 1.42%. The other 1 stocks Mallinckrodt PLC (MNKKQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Angus C. Russell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2021-12-13 | 26,913 | 4.13 | 111,151 |
| LCTX | Lineage Cell Therapeutics Inc | 2021-06-29 | 87,500 | 0.95 | 83,020 |
| TXMD | TherapeuticsMD Inc | 2019-08-23 | 1,870 | 1.50 | 2,805 |
| MNKKQ | Mallinckrodt PLC | 2020-11-12 | 0 | 0.02 | 0 |
Holding Weightings of Angus C. Russell
Angus C. Russell Form 4 Trading Tracker
According to the SEC Form 4 filings, Angus C. Russell has made a total of 1 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Revance Therapeutics Inc is the acquisition of 6,400 shares on December 13, 2021, which cost Angus C. Russell around $100,736.
According to the SEC Form 4 filings, Angus C. Russell has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 4,720 shares on June 29, 2021, which brought Angus C. Russell around $14,018.
According to the SEC Form 4 filings, Angus C. Russell has made a total of 0 transactions in TherapeuticsMD Inc (TXMD) over the past 5 years. The most-recent trade in TherapeuticsMD Inc is the acquisition of 200 shares on August 23, 2019, which cost Angus C. Russell around $27,700.
More details on Angus C. Russell's insider transactions can be found in the Insider Trading History of Angus C. Russell table.Insider Trading History of Angus C. Russell
- 1
Angus C. Russell Trading Performance
GuruFocus tracks the stock performance after each of Angus C. Russell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Angus C. Russell is 0.2%. GuruFocus also compares Angus C. Russell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Angus C. Russell within 3 months outperforms 3 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Angus C. Russell's insider trading performs compared to the benchmark.
Performance of Angus C. Russell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.69 | | | | | |
| Relative Return to S&P 500(%) | 12.47 | | | | | |
Angus C. Russell Ownership Network
Ownership Network List of Angus C. Russell
Ownership Network Relation of Angus C. Russell
Angus C. Russell Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Who are the key executives at Lineage Cell Therapeutics Inc?
Angus C. Russell is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , director & President and CEO Brian M Culley , and 10 percent owner Broadwood Partners Lp .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Angus C. Russell made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,500 shares made by Jill Ann Howe .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 10,500 shares, with a net purchase of 10,500 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,857,425 shares were bought by its insiders, resulting in a net purchase of 6,857,425 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lineage Cell Therapeutics Inc Insider Transactions
Angus C. Russell Mailing Address
Above is the net worth, insider trading, and ownership report for Angus C. Russell. You might contact Angus C. Russell via mailing address: C/o Intermune, Inc., 3280 Bayshore Boulevard, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
